{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T11:30:50Z","timestamp":1793705450389,"version":"4.5.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["lipidjournal.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jacl.2024.05.009","type":"journal-article","created":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T00:35:07Z","timestamp":1717720507000},"page":"e746-e755","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["The role of residual inflammatory risk and LDL cholesterol in patients with in-stent restenosis undergoing percutaneous coronary intervention"],"prefix":"10.1016","volume":"18","author":[{"given":"Han","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chujie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenghuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kefei","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubin","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changdong","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2024.05.009_bib0001","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jacc.2019.11.058","article-title":"Stent-related adverse events >1 year after percutaneous coronary intervention","volume":"75","author":"Madhavan","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2024.05.009_bib0002","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.jacc.2020.08.002","article-title":"Trends and outcomes of restenosis after coronary stent implantation in the United States","volume":"76","author":"Moussa","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2024.05.009_bib0003","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4244\/AIJ-D-22-00005","article-title":"Aggressive lipid-lowering therapy after percutaneous coronary intervention - for whom and how?","volume":"8","author":"Lee","year":"2022","journal-title":"AsiaIntervention"},{"key":"10.1016\/j.jacl.2024.05.009_bib0004","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(23)00215-5","article-title":"Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials","volume":"401","author":"Ridker","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2024.05.009_bib0005","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1093\/eurheartj\/ehu059","article-title":"C-reactive protein and risk of cardiovascular and all-cause mortality in 268 803 East Asians","volume":"35","author":"Sung","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2024.05.009_bib0006","first-page":"2525","article-title":"Inflammation during the life cycle of the atherosclerotic plaque","volume":"117","author":"Libby","year":"2021","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacl.2024.05.009_bib0007","first-page":"323","article-title":"Residual inflammatory risk and its association with events in East Asian patients after coronary intervention","volume":"2","author":"Ahn","year":"2022","journal-title":"JACC: Asia"},{"key":"10.1016\/j.jacl.2024.05.009_bib0008","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.jcin.2011.05.025","article-title":"Vascular inflammation and repair: implications for re-endothelialization, restenosis, and stent thrombosis","volume":"4","author":"Inoue","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacl.2024.05.009_bib0009","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1093\/ehjci\/jeu035","article-title":"Association between inflammatory biomarkers and in-stent restenosis tissue features: an optical coherence tomography study","volume":"15","author":"Niccoli","year":"2014","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jacl.2024.05.009_bib0010","first-page":"23","article-title":"Association between lipoprotein(a) and long-term outcomes after percutaneous coronary intervention for lesions with in-stent restenosis","author":"Zhang","year":"2023","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2024.05.009_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.jscai.2023.100971","article-title":"SCAI Expert consensus statement on management of in-stent restenosis a nd stent thrombosis","volume":"2","author":"Klein","year":"2023","journal-title":"J Society for Cardiovascul Angiography & Intervent"},{"key":"10.1016\/j.jacl.2024.05.009_bib0012","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"72","author":"Thygesen","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2024.05.009_bib0013","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1001\/jama.2018.2525","article-title":"Association between baseline LDL-C level and total and cardiovascular mortality after LDL-C lowering: a systematic review and meta-analysis","volume":"319","author":"Navarese","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jacl.2024.05.009_bib0014","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.4244\/EIJ-D-21-01034","article-title":"Management of in-stent restenosis","volume":"18","author":"Alfonso","year":"2022","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jacl.2024.05.009_bib0015","first-page":"11","article-title":"Differential expression of miRNA-223 in coronary in-stent restenosis","author":"Ganjali","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.jacl.2024.05.009_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamacardio.2021.1810","article-title":"Use of lipid-lowering therapies over 2 Years in GOULD, a registry of patients with atherosclerotic cardiovascular disease in the US","volume":"6","author":"Cannon","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacl.2024.05.009_bib0017","first-page":"0","article-title":"Inflammation and cholesterol as predictors of cardiovascular events among 13970 contemporary high-risk patients with statin intolerance","author":"Ridker","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2024.05.009_bib0018","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.immuni.2021.12.013","article-title":"Inflammation in obesity, diabetes, and related disorders","volume":"55","author":"Rohm","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.jacl.2024.05.009_bib0019","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12933-017-0613-8","article-title":"The anti-inflammatory function of HDL is impaired in type 2 diabetes: role of hyperglycemia, paraoxonase-1 and low grade inflammation","volume":"16","author":"Ebtehaj","year":"2017","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jacl.2024.05.009_bib0020","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1016\/j.jacc.2021.04.059","article-title":"Triglycerides and residual atherosclerotic risk","volume":"77","author":"Raposeiras-Roubin","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2024.05.009_bib0021","doi-asserted-by":"crossref","first-page":"C2","DOI":"10.1093\/eurheartj\/suw009","article-title":"Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia","volume":"18","author":"Ferrari","year":"2016","journal-title":"Eur Heart J Suppl."},{"key":"10.1016\/j.jacl.2024.05.009_bib0022","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4244\/EIJ-D-23-00606","article-title":"Targeting inflammation in atherosclerosis: overview, strategy and directions","volume":"20","author":"Waksman","year":"2024","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jacl.2024.05.009_bib0023","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jacc.2023.05.055","article-title":"Low-dose colchicine for secondary prevention of coronary artery disease: JACC review topic of the week","volume":"82","author":"Nelson","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2024.05.009_bib0024","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1001\/jamacardio.2021.3508","article-title":"Association between cumulative low-density lipoprotein cholesterol exposure during young adulthood and middle age and risk of cardiovascular events","volume":"6","author":"Zhang","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacl.2024.05.009_bib0025","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/2047487320941987","article-title":"Intensity of statin treatment after acute coronary syndrome, residual risk, and its modification by alirocumab: insights from the ODYSSEY OUTCOMES trial","volume":"28","author":"Diaz","year":"2021","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacl.2024.05.009_bib0026","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/cvr\/cvae034","article-title":"Effect of lipid-lowering therapies on C-reactive protein levels: a comprehensive meta-analysis of randomized controlled trials","volume":"120","author":"Xie","year":"2024","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacl.2024.05.009_bib0027","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1093\/eurheartj\/ehy633","article-title":"Residual inflammatory risk and the impact on clinical outcomes in patients after percutaneous coronary interventions","volume":"39","author":"Kalkman","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2024.05.009_bib0028","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"New Engl J Med."},{"key":"10.1016\/j.jacl.2024.05.009_bib0029","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"LoDoCo2 Trial I. colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"New Engl J Med."},{"key":"10.1016\/j.jacl.2024.05.009_bib0030","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/S0140-6736(21)00520-1","article-title":"IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"397","author":"Ridker","year":"2021","journal-title":"Lancet"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287424002010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287424002010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T11:32:55Z","timestamp":1732620775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287424002010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1933287424002010"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2024.05.009","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of residual inflammatory risk and LDL cholesterol in patients with in-stent restenosis undergoing percutaneous coronary intervention","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2024.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 National Lipid Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}